Marc Andreessen famously proclaimed in 2011 that “software is eating the world”. Fast forward to today and it’s data eating the world. Data is growing somewhat faster or much faster than other types of data in 71% of enterprises according to Western Digital. By 2025, there will be 175 zettabytes (10,000 TB) of data. Solidatus is a metadata management and data lineage platform that’s focused on how enterprises view, manage, and understand their growing mounds of data. The company focuses on letting its customers harness the data economy, whether it’s for compliance, governance, introducing efficiencies, or even digital transformation efforts. Solidatus is currently used in a variety of industries including pharmaceuticals, banking, aerospace, manufacturing, consulting, and telecommunications. In 2020 alone, the company was able to quadruple its revenue as the pandemic introduced new complexities for data management across location and geography. London TechWatch caught up with Cofounder Philip Miller to learn more about the company, its future plans, and recent round of funding from investors that include AlbionVC, HSBC Venture,s and Citi.
In the insurance industry, any information that helps assess risk is absolutely critical when it comes to underwriting and specialty marine insurance is no different. Concirrus is the intelligence platform that helps all relevant parties in the insurance industry (asset owners, insurers, brokers, and investors) understand true risk in real-time. CEO and Cofounder Andy Yeoman shares some insights on bringing sophisticated intelligence to the insurtech space, the company’s future plans, and recent round of funding, which brings the total funding raised to £31.1M.
It’s an unprecedented time to study genetics because technological advancements and the raw computational power available are helping scientists make sense of DNA in an unprecedented way. Lifebit CEO Dr. Maria Chatzou Dunford offers some insight on how her company’s platform allows researchers to analyse data faster than ever and extract actionable insights to develop better drugs, therapies, diagnostics, and products.
Data in all formats will soon be the largest source of new opportunities for startups or death.